Sanofi
Sanofi will implement BenchSci's Ascend across its global research organization.
The company's platform predicts how people in a clinical trial will respond to treatment.
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
They will deliver connected caps for insulin and titration alerts to Japanese healthcare providers and patients.
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
This news comes just months after Exscientia went public.
The digital tool will be first marketed in Taiwan following regulatory approvals.
The joint venture will enable the companies to collaborate through a virtual platform and physical base in Paris.